Cytokinetics CYTK
NASDAQ CYTK
$58.35 +2.17 (+3.86%)
As of: Nov 11, 2026 · 3:23 PM EST

Cytokinetics (CYTK) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Cytokinetics (CYTK) recorded Return on Capital Employed [ROCE] of -46.56% in Q3 2026, up 1.63 percentage points from -48.19% a year earlier and up 3.38 percentage points from the prior quarter.

Analysis

Cytokinetics (CYTK) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Cytokinetics reported Return on Capital Employed [ROCE] of -50.57%, up 6.88 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -25.89 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -57.46% in FY2024 (+3.29 pp), -60.74% in FY2023 (-22.31 pp), -38.44% in FY2022 (-8.18 pp) and -30.26% in FY2021 (-5.58 pp).
  • The Q3 2026 figure is the highest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in three of the last eight quarters, with an average year-over-year change of +3.17 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 34.35 percentage points in Q3 2024, against a drop of 46.81 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -49.94% (Q2 2026), -55.68% (Q1 2026) and -49.85% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn -46.56%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -46.56%
Jun 30, 2026 -49.94%
Mar 31, 2026 -55.68%
Dec 31, 2025 -49.85%
Sep 30, 2025 -48.19%
Jun 30, 2025 -49.11%
Mar 31, 2025 -48.22%
Dec 31, 2024 -43.27%
Sep 30, 2024 -38.29%
Jun 30, 2024 -47.60%
Mar 31, 2024 -68.46%
Dec 31, 2023 -72.99%
Sep 30, 2023 -72.64%
Jun 30, 2023 -62.66%
Mar 31, 2023 -42.28%
Dec 31, 2022 -33.74%
Sep 30, 2022 -25.83%
Jun 30, 2022 -24.04%
Mar 31, 2022 -28.59%
Dec 31, 2021 -24.43%
API Access

Cytokinetics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEY